Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody.

Author: Fang LI ¹ ; Meng LUO ² ; Wenyang ZHOU ² ; Jinliang LI ³ ; Xiyun JIN ² ; Zhaochun XU ² ; Liran JUAN ² ; Zheng ZHANG ³ ; Yuou LI ³ ; Renqiang LIU ¹ ; Yiqun LI ² ; Chang XU ² ; Kexin MA ² ; Huimin CAO ² ; Jingwei WANG ³ ; Pingping WANG ⁴ ; Zhigao BU ⁵ ; Qinghua JIANG ⁶
Author Information

1. State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150001, China.
2. School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150000, China.
3. Harbin Sixth Hospital, Harbin, 150000, China.
4. School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150000, China. 18B328001@stu.hit.edu.cn.
5. State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, 150001, China. buzhigao@caas.cn.
6. School of Life Science and Technology, Harbin Institute of Technology, Harbin, 150000, China. qhjiang@hit.edu.cn.
Publication Type:Research Support, Non-U.S. Gov't
MeSH: Antibodies, Neutralizing; Antibodies, Viral/isolation & purification*; B-Lymphocytes/virology*; COVID-19/virology*; Humans; Immunity/genetics*; RNA, Viral/immunology*; SARS-CoV-2/pathogenicity*; Single-Cell Analysis
From: Protein & Cell 2021;12(10):751-755
CountryChina
Language:English